Janus Henderson Investors US’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Janus Henderson Investors US’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-437,864	Closed	-$4.86M	–	1201
2015 Q2	$4.86M	Sell	437,864 -1,317,954	-75%	-$17M	﹤0.01%	805
2015 Q1	$27.5M	Buy	1,755,818 +205,845	+13%	+$3.18M	0.02%	557
2014 Q4	$23.6M	Buy	1,549,973 +243,881	+19%	+$2.96M	0.02%	570
2014 Q3	$14.1M	Buy	1,306,092 +446,332	+52%	+$5.83M	0.01%	640
2014 Q2	$13.1M	Buy	859,760 +75,683	+10%	+$1.09M	0.01%	625
2014 Q1	$14.2M	Buy	+784,077	New	+$15.1M	0.01%	602

Other funds holding SGMO

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Investors US's SGMO Position: Q3 2015 in Review

Janus Henderson Investors US sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2015, closing a stake of 437,864 shares — an estimated $4.86M sold.

Janus Henderson Investors US first reported a position in SGMO in Q1 2014 and held it in 6 quarters. The position peaked at $27.5M in Q1 2015. 141 funds tracked by Wall St. Rank hold SGMO as of Q3 2015.

Janus Henderson Investors US reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2015 after selling out during the quarter.
Janus Henderson Investors US sold 437,864 SANGAMO THERAPEUTICS INC shares in Q3 2015, an estimated $4.86M.
Janus Henderson Investors US first reported a position in SANGAMO THERAPEUTICS INC in Q1 2014 and held it in 6 quarters.
Janus Henderson Investors US's SANGAMO THERAPEUTICS INC position peaked at $27.5M in Q1 2015.
141 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2015.

Based on Janus Henderson Investors US's 13F filing for Q3 2015, filed 17 Nov 2015.